Canada Pension Plan Investment Board purchased a new stake in NxStage Medical, Inc. (NASDAQ:NXTM) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 279,400 shares of the medical device company’s stock, valued at approximately $7,792,000.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Janus Henderson Group PLC raised its stake in NxStage Medical by 25.5% in the 3rd quarter. Janus Henderson Group PLC now owns 10,505 shares of the medical device company’s stock valued at $293,000 after acquiring an additional 2,134 shares during the period. Rhumbline Advisers raised its stake in NxStage Medical by 3.5% in the 2nd quarter. Rhumbline Advisers now owns 67,450 shares of the medical device company’s stock valued at $1,882,000 after acquiring an additional 2,250 shares during the period. Public Employees Retirement Association of Colorado raised its stake in NxStage Medical by 63.8% in the 3rd quarter. Public Employees Retirement Association of Colorado now owns 8,635 shares of the medical device company’s stock valued at $241,000 after acquiring an additional 3,362 shares during the period. NumerixS Investment Technologies Inc bought a new stake in NxStage Medical in the 2nd quarter valued at $122,000. Finally, Levin Capital Strategies L.P. raised its stake in NxStage Medical by 38.6% in the 3rd quarter. Levin Capital Strategies L.P. now owns 21,018 shares of the medical device company’s stock valued at $586,000 after acquiring an additional 5,857 shares during the period. Institutional investors and hedge funds own 83.58% of the company’s stock.

NXTM stock opened at $28.86 on Friday. The firm has a market cap of $1.90 billion, a price-to-earnings ratio of -131.18 and a beta of 0.05. NxStage Medical, Inc. has a fifty-two week low of $22.70 and a fifty-two week high of $29.26.

NxStage Medical (NASDAQ:NXTM) last posted its quarterly earnings data on Wednesday, November 7th. The medical device company reported $0.01 earnings per share for the quarter, topping the consensus estimate of ($0.02) by $0.03. The firm had revenue of $108.12 million for the quarter, compared to analysts’ expectations of $108.07 million. NxStage Medical had a negative return on equity of 2.50% and a negative net margin of 1.29%. On average, sell-side analysts forecast that NxStage Medical, Inc. will post -0.02 earnings per share for the current fiscal year.

A number of equities research analysts recently weighed in on NXTM shares. Zacks Investment Research cut NxStage Medical from a “hold” rating to a “sell” rating in a research note on Saturday, August 11th. BidaskClub cut NxStage Medical from a “hold” rating to a “sell” rating in a research report on Friday, August 31st. Finally, ValuEngine upgraded NxStage Medical from a “hold” rating to a “buy” rating in a research report on Friday, October 12th.

COPYRIGHT VIOLATION NOTICE: This story was posted by Daily Political and is the property of of Daily Political. If you are reading this story on another website, it was illegally copied and republished in violation of US and international copyright and trademark laws. The original version of this story can be accessed at https://www.dailypolitical.com/2018/12/08/279400-shares-in-nxstage-medical-inc-nxtm-purchased-by-canada-pension-plan-investment-board.html.

NxStage Medical Company Profile

NxStage Medical, Inc, a medical technology company, develops, manufactures, and markets products and services for patients suffering from chronic or acute kidney failure. Its primary product includes the System One, a portable hemodialysis system, which is used primarily for home hemodialysis and a range of dialysis therapies to deliver in the home setting.

Recommended Story: S&P 500 Index

Want to see what other hedge funds are holding NXTM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for NxStage Medical, Inc. (NASDAQ:NXTM).

Institutional Ownership by Quarter for NxStage Medical (NASDAQ:NXTM)

Receive News & Ratings for NxStage Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NxStage Medical and related companies with MarketBeat.com's FREE daily email newsletter.